Winnebago Industries Reports First Quarter Fiscal 2026 Results -- Quarterly Net Revenues Increase 12.3%, Driven by Growth in Motorhome and Towable RV Segments -- -- Improved Top-Line Performance and Cost Discipline Deliver Margin Gains and Strengthen Balance Sheet -- -- Barletta Continues Share Expansion in U.S. Aluminum Pontoon Segment(1) -- -- Motorized Offerings from Newmar and Grand Design Fuel Share Growth in Class A and Class C(1) -- -- Company Raises FY 2026 Earnings Guidance Range -- EDEN PRAIRIE, Minn., Dec. 19, 2025 (GLOBE NEWSWIRE) -- Winnebago Industries, Inc. (NYSE:...
MediciNova Announces Completion of Patient Enrollment Evaluating MN-166 (ibudilast) in the Prevention of Chemotherapy-induced Peripheral Neuropathy LA JOLLA, Calif., Dec. 18, 2025 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today announced the successful completion of patient enrollment in the randomized, placebo-controlled Phase 2 clinical trial, the OXTOX study (Oxaliplatin Neurotoxicity study in patients with metastatic colorectal cancer). This...
Winnebago Industries Board of Directors names John Murabito as chair; Declares quarterly cash dividend EDEN PRAIRIE, Minn., Dec. 17, 2025 (GLOBE NEWSWIRE) -- Winnebago Industries, Inc. (NYSE: WGO) a premium outdoor recreation product manufacturer, announced today that John M. Murabito, an independent director since 2017, has been appointed as chair of the board. He succeeds David W. Miles, who has served as chair since 2019 and will remain on the board as a continuing member. The company also announced today that its board of directors has declared a quarterly cash distribution of $0.35 p...
Simply Good Foods to Report First Quarter Fiscal Year 2026 Financial Results on Thursday, January 8, 2026 DENVER, Dec. 17, 2025 (GLOBE NEWSWIRE) -- The Simply Good Foods Company (NASDAQ: SMPL) (“Simply Good Foods” or the “Company”), a leader in the Nutritional Snacking category, today announced it will report financial results for the first quarter of Fiscal Year 2026 on Thursday, January 8, 2026. A press release will be issued that morning, followed by a live conference call beginning at 6:30 a.m. Mountain Time (8:30 a.m. Eastern Time). Participating on the call will be Geoff Tanner, Pre...
Winnebago Industries Celebrates Industry Recognition Across Its Premium RV Brands: Winnebago, Newmar and Grand Design EDEN PRAIRIE, Minn., Dec. 15, 2025 (GLOBE NEWSWIRE) -- Winnebago Industries, Inc. (NYSE: WGO), a leading outdoor recreation product manufacturer, is proud to announce that its three premium RV brands—Winnebago, Newmar and Grand Design—have been honored with multiple awards and accolades from leading industry publications as part of the 2026 model year rollout. These recognitions underscore the company’s commitment to innovation, quality and delivering exceptional experienc...
A director at Stitch Fix Inc sold 303,450 shares at 5.188USD and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly...
MediciNova Announces Update and Basic Characteristic Randomized Patients’ of Phase 2/3 Clinical Trial of MN-166 (Ibudilast) in ALS (COMBAT-ALS Clinical Trial) Presented at the 36th International Symposium on ALS/MND LA JOLLA, Calif., Dec. 08, 2025 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company listed on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of the Tokyo Stock Exchange (Code: 4875), today announced an update and the patients’ basic characteristics data from its Phase 2b/3 clinical trial of MN-166 (ibudilast) in Amyotrophic Lateral Sclerosis (ALS...
KALA BIO Announces Closing of $10 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules ARLINGTON, Mass., Dec. 05, 2025 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ:KALA) (“KALA” or the “Company”), today announced the closing of its previously announced registered direct offering priced at-the-market under Nasdaq rules for the purchase of an aggregate of 10,000,000 shares of its common stock (or pre-funded warrants in lieu thereof), at a purchase price of $1.00 per share (or pre-funded warrant in lieu thereof). H.C. Wainwright & Co. acted as the exclusi...
Short Shots is a collection of technically vulnerable charts culled from the Negative Inflecting and Toppy columns within our Weekly Compass report or from various technical screening processes. The charts contained in this report have developed concerning technical patterns that suggest further price deterioration is likely. For these reasons Short Shots can also be a great source of ideas for investors interested in short-selling candidates.
KALA BIO Announces $10 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules ARLINGTON, Mass., Dec. 04, 2025 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ:KALA) (“KALA” or the “Company”), today announced that it has entered into definitive agreements for the purchase of an aggregate of 10,000,000 shares of its common stock (or pre-funded warrants in lieu thereof), at a purchase price of $1.00 per share (or pre-funded warrant in lieu thereof) in a registered direct offering priced at-the-market under Nasdaq rules. The closing of the offering is expected to...
Winnebago Industries to Announce First Quarter Fiscal 2026 Financial Results on December 19, 2025 EDEN PRAIRIE, Minn., Dec. 04, 2025 (GLOBE NEWSWIRE) -- Winnebago Industries, Inc. (NYSE: WGO), a leading outdoor recreation product manufacturer, plans to issue its first quarter fiscal 2026 financial results before the opening of the New York Stock Exchange on Friday, December 19, 2025. At 9:00 a.m. CT, the company will conduct a conference call hosted by Michael Happe, president and chief executive officer, and Bryan Hughes, senior vice president and chief financial officer. You are invite...
Winnebago Industries named one of America’s Most Responsible Companies for fourth consecutive year Company recognized by Newsweek for its commitment to corporate responsibility and sustainability EDEN PRAIRIE, Minn., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Winnebago Industries, Inc. (NYSE: WGO), a leading manufacturer of outdoor recreation products, has been named one of America’s Most Responsible Companies by Newsweek for the fourth year in a row. The recognition highlights the company’s continued commitment to corporate responsibility, sustainability and social impact. “We are honored to b...
Message from the CEO to MediciNova Shareholders Strengthening MN-001’s Scientific Foundation and Clinical Outlook LA JOLLA, Calif., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Dear Fellow Shareholders, Following the recent publication in the Journal of Atherosclerosis and Thrombosis, I would like to provide additional perspective on why this research represents a significant milestone for MediciNova and our MN-001 program. The study, conducted in collaboration with a leading Japanese academic research team, revealed a novel mechanism by MN-002, the primary metabolite of MN-001, enhances choles...
KALA BIO Enters Into $6 Million Securities Purchase Agreement with Investor David E. Lazar Investment to support the continued evaluation and redevelopment of KALA’s product candidates and patent portfolio, and provide working capital and funding for a potential future strategic transaction ARLINGTON, Mass., Dec. 01, 2025 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of innovative therapies for rare and severe diseases of the eye, announces it has entered into a $6 million securit...
A director at Williams Sonoma Inc sold 30,000 shares at 179.549USD and the significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cl...
In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
MediciNova Appoints Dr. Christopher Breder, MD, PhD as Clinical and Regulatory Advisor LA JOLLA, Calif., Nov. 18, 2025 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), is pleased to announce the appointment of Dr. Christopher D. Breder, MD, PhD as Clinical and Regulatory Advisor. Dr. Breder will provide strategic guidance for MediciNova’s Drug Development programs and will lead the Scientific Advisory Board upon its formation. Dr. Christopher D. Brede...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.